C
3.88
0.00 (0.00%)
| Penutupan Terdahulu | 3.88 |
| Buka | 3.79 |
| Jumlah Dagangan | 21,039 |
| Purata Dagangan (3B) | 106,544 |
| Modal Pasaran | 55,150,248 |
| Harga / Jualan (P/S) | 220.99 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 13 Aug 2025 |
| Margin Operasi (TTM) | -5,032.10% |
| EPS Cair (TTM) | -4.03 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 11.00% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 760.79% |
| Nisbah Semasa (MRQ) | 1.36 |
| Aliran Tunai Operasi (OCF TTM) | -19.25 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -8.61 M |
| Pulangan Atas Aset (ROA TTM) | -49.62% |
| Pulangan Atas Ekuiti (ROE TTM) | -1,738.36% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Packaged Foods (US) | Bercampur | Menurun |
| Packaged Foods (Global) | Bercampur | Bercampur | |
| Stok | Clene Inc. | Bercampur | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.9 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -2.0 |
| Penilaian Relatif | NA |
| Kesihatan Kewangan | -4.0 |
| Persekitaran Makro | -2.8 |
| AI Insight | NA |
| AI Technical | NA |
| Purata | -1.07 |
|
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46. |
|
| Sektor | Consumer Defensive |
| Industri | Packaged Foods |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 34.60% |
| % Dimiliki oleh Institusi | 16.99% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Lunt Capital Management, Inc. | 30 Jun 2026 | 52,260 |
| Parsons Capital Management Inc/Ri | 30 Jun 2026 | 37,243 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |